No FDA-approved human dose exists for either peptide, so there is no correct dose to state only what investigators used under monitoring
Collagen: Equivalent to 1,000 mg*
Currently, NICE-approved pharmaceutical options include orlistat (a lipase inhibitor) and, more recently, semaglutide (Wegovy) for specific patient groups meeting eligibility criteria
Answering these questions before compound selection helps ensure the experimental design aligns with what has already been established in the literature, rather than treating AOD-9604, Semaglutide and tesamorelin as functionally equivalent simply because theyre all studied in the context of fat metabolism
On average, without insurance, semaglutide (under the brand names Ozempic and Wegovy) can cost between $800 and $1,200 per month